Cart is empty The U.S. Food and Drug Administration has expanded its indication of ALK’s Odactra, a house dust mite allergen tablet, for the treatment of house dust mite-induced allergic rhinitis, with or without conjunctivitis, to include children ages 5 through 11 years.
Leave A Comment